Literature DB >> 11147747

Serotonergic antidepressants and urinary incontinence.

N A Votolato1, S Stern, R M Caputo.   

Abstract

Many new serotonergic antidepressants have been introduced over the past decade. Although urinary incontinence is listed as one side effect of these drugs in their package inserts there is only one report in the literature. This concerns 2 male patients who experienced incontinence while taking venlafaxine. In the present paper the authors describe 2 female patients who developed incontinence secondary to the selective serotonin reuptake inhibitors paroxetine and sertraline, as well as a third who developed this side effect on venlafaxine. In 2 of the 3 cases the patients were also taking lithium carbonate and beta-blockers, both of which could have contributed to the incontinence. Animal studies suggest that incontinence secondary to serotonergic antidepressants could be mediated by the 5HT4 receptors found on the bladder. Further research is needed to delineate the frequency of this troubling side effect and how best to treat it.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11147747     DOI: 10.1007/s001920070009

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  13 in total

Review 1.  Tolerability of selective serotonin reuptake inhibitors: issues relevant to the elderly.

Authors:  Brian Draper; Karen Berman
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

2.  Venlafaxine compromises the antinociceptive actions of gabapentin in rat models of neuropathic and persistent pain.

Authors:  Frederik Rode; Tine Broløs; Gordon Blackburn-Munro; Ole J Bjerrum
Journal:  Psychopharmacology (Berl)       Date:  2006-06-17       Impact factor: 4.530

3.  Potential targets in the treatment of urinary incontinence.

Authors:  W Steers
Journal:  Rev Urol       Date:  2001

4.  Dose-Dependent Urinary Incontinence with Sertraline Use in Obsessive-Compulsive Disorder.

Authors:  Eric Pease; Balwinder Singh; Matthew Ziegelmann; Hannah Betcher
Journal:  Psychopharmacol Bull       Date:  2021-11-03

5.  Optimising the management of children with concomitant bladder dysfunction and behavioural disorders.

Authors:  Dilharan D Eliezer; Christopher Lam; Angela Smith; John Mithran Coomarasamy; Naeem Samnakay; Malcolm R Starkey; Aniruddh V Deshpande
Journal:  Eur Child Adolesc Psychiatry       Date:  2022-06-29       Impact factor: 5.349

Review 6.  Drug-induced urinary incontinence.

Authors:  Peter Tsakiris; Matthias Oelke; Martin C Michel
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 7.  Pharmacotherapy for stress urinary incontinence : present and future options.

Authors:  Norman R Zinner; Stephanie C Koke; Lars Viktrup
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Effects of sertraline on autonomic and cognitive functions in healthy volunteers.

Authors:  Martin Siepmann; Jens Grossmann; Michael Mück-Weymann; Wilhelm Kirch
Journal:  Psychopharmacology (Berl)       Date:  2003-04-12       Impact factor: 4.530

9.  Assessment of overactive bladder in women antidepressant users.

Authors:  Sebahattin Albayrak; Volkan Solmaz; Yusuf Gencden; Fatih Firat; Meral Oran Demir; Durdane Aksoy; Nermin Tanik; Serhat Tanik; Fikret Erdemir
Journal:  Int Urol Nephrol       Date:  2015-08-06       Impact factor: 2.370

10.  Impaired detrusor contractility due to venlafaxine use.

Authors:  J Torgovnick; N K Sethi; P K Sethi; E Arsura
Journal:  Indian J Urol       Date:  2008-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.